Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Older iPhones Cutting Into Apple Inc. (AAPL) iPhone 5 Sales

Page 1 of 2

Apple Inc. (NASDAQ:AAPL) will report its first quarter financials in late January, and obviously, iPhone 5 sales will be important. Now it can be said with near-absolute certainty that every analyst under the sun is expecting the iPad Mini to cannibalize the company’s larger tablet models to an extent, but some may have not expected that older “legacy” iPhones would cut into sales of the iPhone 5.

Apple Inc. (NASDAQ:AAPL)

As originally reported by AllThingsD earlier today, a research report from Consumer Intelligence Research Partners shows that “by some metrics, the iPhone 5 underperformed compared to its predecessor, the iPhone 4S.” More specifically, “the iPhone 5 accounted for 68 percent of total iPhone sales during its first month at market — significantly less than the iPhone 4S, which accounted for 90 percent of all iPhone sales during its first month of retail availability.”

In October 2011 after Apple Inc. (NASDAQ:AAPL)’s iPhone 4S launched, just 7% of smartphone sales were derived from the previous version (iPhone 4), while the remaining 3% was attributed to sales of the iPhone 3GS. This time around, however, the immediate predecessor iPhone 4S is still snatching up 23% of sales, and the iPhone 4 (remarkably) still accounts for 9% of Apple’s smartphone revenue.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!